Warner Pharmaceuticals: 2023 Annual Equity Distribution Implementation Notice
Response to the inquiry letter on the review of application documents for the issuance of convertible corporate bonds by Hunan Warner Pharmaceutical Co., Ltd. to unspecified targets (revised draft)
Response to the inquiry letter on the review of application documents for the issuance of convertible corporate bonds by Hunan Warner Pharmaceutical Co., Ltd. to unspecified targets (revised draft)
Response to the inquiry letter on the review of application documents for the issuance of convertible corporate bonds by Hunan Warner Pharmaceutical Co., Ltd. to unspecified targets
Warner Pharmaceutical: Tianjian Certified Public Accountants (Special General Partnership) Financial statements and audit reports on the issuance of convertible corporate bonds by Hunan Warner Pharmaceutical Co., Ltd. to unspecified targets
Warner Pharmaceuticals: Announcement on the Application for Issuance of Convertible Corporate Bonds to Unspecified Targets Accepted by the Shanghai Stock Exchange
Warner Pharmaceuticals: An Empirical Analysis Report on Issuing Convertible Corporate Bonds to Unspecified Targets
Warner Pharmaceuticals: Feasibility analysis report on the use of funds raised by issuing convertible corporate bonds to unspecified targets
Warner Pharmaceuticals: Announcement on Issuance of Convertible Corporate Bonds to Unspecified Targets to Dilute Immediate Returns and Compensation Measures and Related Entities' Commitments
Warner Pharmaceuticals: 2021 Annual Equity Distribution Implementation Notice
2021 Annual Equity Distribution Implementation Notice
Warner Pharmaceuticals: Announcement on the Company's 2021 Annual Profit Distribution Plan
No Data